{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,7,23]],"date-time":"2025-07-23T12:11:46Z","timestamp":1753272706481,"version":"3.40.5"},"reference-count":40,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"33","license":[{"start":{"date-parts":[[2024,8,16]],"date-time":"2024-08-16T00:00:00Z","timestamp":1723766400000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc\/4.0\/"}],"content-domain":{"domain":["lww.com","ovid.com"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2024,8,16]]},"abstract":"<jats:p>Nursing and physical examination early screening of multiple tumors is helpful to find tumors early, so as to improve the cure rate. Studying its molecular mechanisms is urgent. By logging into gene expression omnibus database, we found laryngeal cancer dataset GSE127165, bladder cancer dataset GSE65635, oral cancer dataset GSE146483, obtain differentially expressed genes, subsequently, weighted gene co-expression network analysis, protein\u2013protein interaction networks, functional enrichment analysis, immune infiltration analysis, survival analysis, comparative toxicogenomics database analysis were conducted. Draw a heatmap of gene expression. Use targetScan to search for miRNA information about core DEG. Got 53 differentially expressed genes. In GOKEGG analysis, they were clustered in cell cycle processes, spindle poles, and protein serine\/threonine\/tyrosine kinase activity cell cycle, transcriptional dysregulation in cancer, RIG-I-like receptor signaling pathway, P53 signaling pathway. Protein\u2013protein interaction analysis screened out 5 genes (NEK2, BUB1, HMMR, TTK, CCNB2). Cyclin B2 (CCNB2) and budding uninhibited by benzimidazole 1 (BUB1) were highly expressed in laryngeal cancer, bladder cancer, oral cancer. Comparative toxicogenomics database analysis found that core genes (CCNB2, BUB1) are associated with tumors, necrosis, and inflammation. Related miRNA of CCNB2 gene is hsa-miR-670-3p; related miRNAs of BUB1 gene are hsa-miR-5688, hsa-miR-495-3p. CCNB2 and BUB1 exhibit high expression in laryngeal cancer, bladder cancer, and oral cancer, suggesting their potential as molecular targets for precision therapy in these cancers.<\/jats:p>","DOI":"10.1097\/md.0000000000039231","type":"journal-article","created":{"date-parts":[[2024,8,17]],"date-time":"2024-08-17T00:01:12Z","timestamp":1723852872000},"page":"e39231","update-policy":"https:\/\/doi.org\/10.1097\/lww.0000000000001000","source":"Crossref","is-referenced-by-count":1,"title":["Exploration of biomarkers for nursing physical examination early screening of multiple tumors"],"prefix":"10.1097","volume":"103","author":[{"ORCID":"https:\/\/orcid.org\/0009-0004-4647-9392","authenticated-orcid":false,"given":"Xuepu","family":"Li","sequence":"first","affiliation":[{"name":"Health Management Center for Model Workers, Beijing Rehabilitation Hospital Affiliated to Capital Medical University, Xixiazhuang, Badachu, Shijingshan District, Beijing, China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ruipu","family":"Li","sequence":"additional","affiliation":[{"name":"Gastrointestinal Rehabilitation Center, Beijing Rehabilitation Hospital Affiliated to Capital Medical University, Xixiazhuang, Badachu, Shijingshan District, Beijing, China."}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"276","reference":[{"key":"R1-20250503","doi-asserted-by":"crossref","first-page":"403","DOI":"10.1016\/j.otc.2022.11.005","article-title":"Laryngeal cancer and the end of life (as we know it).","volume":"56","author":"Bodd","year":"2023","journal-title":"Otolaryngol Clin North Am"},{"key":"R2-20250503","doi-asserted-by":"crossref","first-page":"800","DOI":"10.1007\/s40615-021-01018-3","article-title":"Racial and ethnic disparities in laryngeal cancer care.","volume":"9","author":"Cox","year":"2022","journal-title":"J Racial Ethn Health Disparities"},{"key":"R3-20250503","doi-asserted-by":"crossref","first-page":"371","DOI":"10.1016\/j.otc.2022.11.004","article-title":"Swallowing function after treatment of laryngeal cancer.","volume":"56","author":"Brisson-McKenna","year":"2023","journal-title":"Otolaryngol Clin North Am"},{"key":"R4-20250503","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1016\/j.otc.2022.12.006","article-title":"Diagnostic assessment (imaging) and staging of laryngeal cancer.","volume":"56","author":"Itamura","year":"2023","journal-title":"Otolaryngol Clin North Am"},{"key":"R5-20250503","doi-asserted-by":"crossref","first-page":"10","DOI":"10.21147\/j.issn.1000-9604.2020.01.02","article-title":"Incidence and mortality of laryngeal cancer in China, 2015.","volume":"32","author":"He","year":"2020","journal-title":"Chin J Cancer Res"},{"key":"R6-20250503","doi-asserted-by":"crossref","first-page":"107871","DOI":"10.1016\/j.pharmthera.2021.107871","article-title":"Clinical therapies and nano drug delivery systems for urinary bladder cancer.","volume":"226","author":"Jain","year":"2021","journal-title":"Pharmacol Ther"},{"key":"R7-20250503","doi-asserted-by":"crossref","first-page":"571","DOI":"10.5858\/arpa.2017-0539-RA","article-title":"Urinary bladder pathology: World Health Organization classification and American joint committee on cancer staging update.","volume":"143","author":"Wang","year":"2019","journal-title":"Arch Pathol Lab Med"},{"key":"R8-20250503","doi-asserted-by":"crossref","first-page":"445","DOI":"10.1016\/j.hoc.2021.02.001","article-title":"The epidemiology of bladder cancer.","volume":"35","author":"Mossanen","year":"2021","journal-title":"Hematol Oncol Clin North Am"},{"key":"R9-20250503","doi-asserted-by":"crossref","first-page":"100988","DOI":"10.1016\/j.disamonth.2020.100988","article-title":"Epidemiologic aspects of oral cancer.","volume":"66","author":"Sarode","year":"2020","journal-title":"Dis Mon"},{"key":"R10-20250503","doi-asserted-by":"crossref","first-page":"111634","DOI":"10.1016\/j.yexcr.2019.111634","article-title":"Who is who in oral cancer.","volume":"384","author":"Zhang","year":"2019","journal-title":"Exp Cell Res"},{"key":"R11-20250503","doi-asserted-by":"crossref","DOI":"10.3390\/nu13041299","article-title":"Association between oral cancer and diet: an update.","volume":"13","author":"Rodr\u00edguez-Molinero","year":"2021","journal-title":"Nutrients"},{"key":"R12-20250503","doi-asserted-by":"crossref","first-page":"309","DOI":"10.1016\/j.suc.2021.12.007","article-title":"Oral cancer: what the general surgeon should know.","volume":"102","author":"Pan","year":"2022","journal-title":"Surg Clin North Am"},{"key":"R13-20250503","first-page":"42","article-title":"Advanced practice nursing roles, regulation, education, and practice: a global study.","volume":"88","author":"Wheeler","year":"2022","journal-title":"Ann Glob Health"},{"key":"R14-20250503","doi-asserted-by":"crossref","DOI":"10.1515\/ijnes-2018-0082","article-title":"Holistic nursing values in nurse practitioner education.","volume":"16","author":"Kinchen","year":"2019","journal-title":"Int J Nurs Educ Scholarsh"},{"key":"R15-20250503","doi-asserted-by":"crossref","first-page":"1348","DOI":"10.1038\/s41587-021-01108-x","article-title":"Nanopore sequencing technology, bioinformatics and applications.","volume":"39","author":"Wang","year":"2021","journal-title":"Nat Biotechnol"},{"key":"R16-20250503","doi-asserted-by":"crossref","first-page":"1981","DOI":"10.1093\/bib\/bby063","article-title":"A brief history of bioinformatics.","volume":"20","author":"Gauthier","year":"2019","journal-title":"Brief Bioinform"},{"key":"R17-20250503","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1007\/978-1-0716-0327-7_1","article-title":"Bioinformatics for cancer immunotherapy.","volume":"2120","author":"Holtstr\u00e4ter","year":"2020","journal-title":"Methods Mol Biol"},{"key":"R18-20250503","doi-asserted-by":"crossref","first-page":"3705","DOI":"10.1007\/s00405-021-07233-2","article-title":"Prognostic scores in laryngeal cancer.","volume":"279","author":"Woodley","year":"2022","journal-title":"Eur Arch Otorhinolaryngol"},{"key":"R19-20250503","doi-asserted-by":"crossref","first-page":"253","DOI":"10.1016\/j.semcancer.2022.04.002","article-title":"EGFR signaling pathway as therapeutic target in human cancers.","volume":"85","author":"Levantini","year":"2022","journal-title":"Semin Cancer Biol"},{"key":"R20-20250503","doi-asserted-by":"crossref","first-page":"2648","DOI":"10.3390\/cells9122648","article-title":"Cyclin D1 in cancer: a molecular connection for cell cycle control, adhesion and invasion in tumor and stroma.","volume":"9","author":"Montalto","year":"2020","journal-title":"Cells"},{"key":"R21-20250503","doi-asserted-by":"crossref","first-page":"1980","DOI":"10.1001\/jama.2020.17598","article-title":"Bladder cancer: a review.","volume":"324","author":"Lenis","year":"2020","journal-title":"JAMA"},{"key":"R22-20250503","doi-asserted-by":"crossref","first-page":"627","DOI":"10.3233\/CBM-160604","article-title":"MGMT hypermethylation and BCL-2 overexpression associated with superficial bladder cancer and recurrence.","volume":"16","author":"Jahed","year":"2016","journal-title":"Cancer Biomark"},{"key":"R23-20250503","doi-asserted-by":"crossref","first-page":"706","DOI":"10.1016\/j.urolonc.2020.04.006","article-title":"Risk stratification for bladder cancer: biomarkers of inflammation and immune activation.","volume":"38","author":"Nabavizadeh","year":"2020","journal-title":"Urol Oncol"},{"key":"R24-20250503","doi-asserted-by":"crossref","first-page":"114","DOI":"10.1158\/0008-5472.CAN-21-2362","article-title":"FGFR3 Destabilizes PD-L1 via NEDD4 to Control T-cell-mediated bladder cancer immune surveillance.","volume":"82","author":"Jing","year":"2022","journal-title":"Cancer Res"},{"key":"R25-20250503","doi-asserted-by":"crossref","first-page":"736","DOI":"10.1038\/s41415-020-1695-3","article-title":"Oral cancer patients.","volume":"228","author":"Al-Helou","year":"2020","journal-title":"Br Dent J"},{"key":"R26-20250503","doi-asserted-by":"crossref","first-page":"856","DOI":"10.1016\/j.molmed.2018.08.003","article-title":"Cancer-associated PIK3CA mutations in overgrowth disorders.","volume":"24","author":"Madsen","year":"2018","journal-title":"Trends Mol Med"},{"key":"R27-20250503","first-page":"773","article-title":"[Screening core genes and cyclin B2 as a potential diagnosis, treatment and prognostic biomarker of hepatocellular carcinoma based on bioinformatics analysis].","volume":"28","author":"Yang","year":"2020","journal-title":"Zhonghua Gan Zang Bing Za Zhi"},{"key":"R28-20250503","doi-asserted-by":"crossref","DOI":"10.1042\/BSR20211939","article-title":"CCNB2 is a novel prognostic factor and a potential therapeutic target in low-grade glioma.","volume":"42","author":"Wang","year":"2022","journal-title":"Biosci Rep"},{"key":"R29-20250503","doi-asserted-by":"crossref","first-page":"6011","DOI":"10.18632\/aging.204820","article-title":"Budding uninhibited by benzimidazoles-1 (BUB1) regulates EGFR signaling by reducing EGFR internalization.","volume":"15","author":"Nyati","year":"2023","journal-title":"Aging (Albany NY)"},{"key":"R30-20250503","doi-asserted-by":"crossref","first-page":"352","DOI":"10.1016\/j.tibs.2022.01.004","article-title":"The spindle checkpoint proteins BUB1 and BUBR1: (SLiM)ming down to the basics.","volume":"47","author":"Elowe","year":"2022","journal-title":"Trends Biochem Sci"},{"key":"R31-20250503","first-page":"2815","article-title":"Karyopherin subunit-\u03b1 2 expression accelerates cell cycle progression by upregulating CCNB2 and CDK1 in hepatocellular carcinoma.","volume":"15","author":"Gao","year":"2018","journal-title":"Oncol Lett"},{"key":"R32-20250503","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1080\/19768354.2021.1884599","article-title":"Bub1 kinase in the regulation of mitosis.","volume":"25","author":"Kim","year":"2021","journal-title":"Anim Cells Syst (Seoul)"},{"key":"R33-20250503","doi-asserted-by":"crossref","first-page":"e32825","DOI":"10.1097\/MD.0000000000032825","article-title":"CCNB2 as a potential biomarker of bladder cancer via the high throughput technology.","volume":"102","author":"Zhang","year":"2023","journal-title":"Medicine (Baltim)"},{"key":"R34-20250503","doi-asserted-by":"crossref","first-page":"378","DOI":"10.1186\/s13046-021-02179-z","article-title":"BUB1 drives the occurrence and development of bladder cancer by mediating the STAT3 signaling pathway.","volume":"40","author":"Jiang","year":"2021","journal-title":"J Exp Clin Cancer Res"},{"key":"R35-20250503","doi-asserted-by":"crossref","first-page":"3491","DOI":"10.3390\/cancers13143491","article-title":"The origin of stroma influences the biological characteristics of oral squamous cell carcinoma.","volume":"13","author":"Omori","year":"2021","journal-title":"Cancers (Basel)"},{"key":"R36-20250503","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1016\/j.tibs.2010.08.004","article-title":"BUB1 and BUBR1: multifaceted kinases of the cell cycle.","volume":"36","author":"Bolanos-Garcia","year":"2011","journal-title":"Trends Biochem Sci"},{"key":"R37-20250503","first-page":"469","article-title":"Upregulation of cyclin B2 (CCNB2) in breast cancer contributes to the development of lymphovascular invasion.","volume":"12","author":"Aljohani","year":"2022","journal-title":"Am J Cancer Res"},{"key":"R38-20250503","doi-asserted-by":"crossref","first-page":"e925289","DOI":"10.12659\/MSM.925289","article-title":"CDK1, CCNB1, and CCNB2 are prognostic biomarkers and correlated with immune infiltration in hepatocellular carcinoma.","volume":"26","author":"Zou","year":"2020","journal-title":"Med Sci Monit"},{"key":"R39-20250503","first-page":"683","article-title":"[BUB1 gene is highly expressed in gastric cancer: analysis based on Oncomine database and bioinformatics].","volume":"40","author":"Li","year":"2020","journal-title":"Nan Fang Yi Ke Da Xue Xue Bao"},{"key":"R40-20250503","article-title":"BUB1 inhibition sensitizes lung cancer cell lines to radiotherapy and chemoradiotherapy.","author":"Thoidingjam","year":"2024","journal-title":"bioRxiv"}],"container-title":["Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/10.1097\/MD.0000000000039231","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,5,3]],"date-time":"2025-05-03T23:02:34Z","timestamp":1746313354000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/10.1097\/MD.0000000000039231"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,8,16]]},"references-count":40,"journal-issue":{"issue":"33","published-print":{"date-parts":[[2024]]}},"URL":"https:\/\/doi.org\/10.1097\/md.0000000000039231","relation":{},"ISSN":["1536-5964"],"issn-type":[{"type":"electronic","value":"1536-5964"}],"subject":[],"published":{"date-parts":[[2024,8,16]]}}}